Latest News

03
Apr

World Health Organization (WHO) Information Note on Tuberculosis and COVID-19

The World Health Organization (WHO) is advising Member States that are leading the response to the unfolding COVID-19 pandemic. The WHO Global TB Programme, along with WHO regional and country...
Read More
26
Mar

Our latest Newsletter is out amidst the COVID19 pandemic!

Dear friends, colleagues and partners, As COVID-19 spreads across the globe, we hope that each and everyone one of you is keeping safe and taking all the measures you can...
Read More
12
Mar

Press Release: New, shorter treatment to prevent TB to be rolled out in five high-burden TB countries

New, shorter treatment to prevent TB to be rolled out in five high-burden TB countries Three-month regimen expected to prevent TB in those at highest risk of developing the disease,...
Read More
01
Nov

COMMUNIQUE: RIFAPENTINE GLOBAL PRICE DISCOUNT

Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Sanofi SA, and the Stop TB Partnership is pleased to announce a significant reduction in the price of rifapentine (Priftin®)...
Read More
31
Oct

Press Release: Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low, Lower-Middle and Upper-Middle Income Countries

Press Release Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low-, Lower-Middle and Upper-Middle Income Countries Aurum Institute on behalf of the IMPAACT4TB project congratulates Unitaid, the Global Fund to...
Read More